Patent "Antiviral Ricin-like proteins"

Thor Borgford, Twinstrand Therapeutics

International patent: WO 97/41233. Filing date: 29 April 1997. The present invention provides a method of inhibiting or destroying mammalian cells infected with a retrovirus utilizing the proteins of the invention; and pharmaceutical compositions …

Download Document: Patent "Antiviral Ricin-like proteins"

Adobe Acrobat Reader is required to view PDF documents. You may download the free document viewer (Acrobat Reader) from Adobe's web site.

< Back :: Home :: Contact Us :: Privacy Policy

Search

Downloads

Prodrug mechanism
September 22, 2006

Patent "Ricin-like toxins for the treatment of cancer"
June 13, 2006

Patent "Antiviral Ricin-Like Proteins"
December 25, 2001

Patent "Ricin-like toxin variants for treatment of cancer, viral or parasitic infections"
April 30, 1998

Patent "Antiviral Ricin-like proteins"
April 29, 1997

Recent News

Phase I Study of TST10088 to be Presented at 20th EORTC-NCI-AACR Symposium

October 02, 2008

NORTH VANCOUVER, BC, Canada, October 2, 2008 - Investigators at the Princess Margaret Hospital, University of Colorado Cancer Center & BC Cancer Agency will present "Phase I study of the ribosome inactivating protein prodrug TST10088 (TST88) in patients with advanced...

Read more.

Agents of Biodefense in Canada

November 14, 2007

Twinstrand featured in BioBusiness Magazine
October/November 2007 Issue

Read more.

HOME

COMPANY

RESEARCH

APPLICATIONS

PARTNERS

NEWS

LIBRARY

CONTACT US

News